New T2 injectable

Type 2 diabetes European Commission has granted marketing authorization in Europe. For Sanofi’s Suliqua, a once-daily injection for the treatment of adults with Type 2

Read More »

Metformin and gene variants

Researchers in an international study have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may

Read More »

Metformin helps hearts

A Chinese research study of diabetes patients with coronary heart disease concluded that metformin is more effective than glipizide in reducing the risk of major

Read More »